Aridis Pharmaceuticals (ARDS) Financial Statements

Aridis Pharmaceuticals's market cap is currently $8.91K. The company's EPS TTM is $-0.156; its P/E ratio is ―; Aridis Pharmaceuticals is scheduled to report earnings on May 20, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.